Risk-Adapted Active Surveillance After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Press/Media

Period	Jan 7 2025

Media coverage

Title	Risk-Adapted Active Surveillance After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Media name/outlet	The ASCO Post
Country/Territory	United States
Date	01/7/25
URL	https://ascopost.com/news/january-2025/risk-adapted-active-surveillance-after-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-cancer/
Persons	Daniel Geynisman